Cerebral white matter lesions – associations with Aβ isoforms and amyloid PET

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].

Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,010 · see citing works

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review

Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589 · see citing works

Older Adults' Reasons for Using Technology while Aging in Place

Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,803 · see citing works

Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly

Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,003 · see citing works

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,560 · see citing works

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

Fazekas, F., Chawluk, J. B., Alavi, A. A., Hurtig, H. I., & Zimmerman, R. A. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,327 · see citing works

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405 · see citing works

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · see citing works

Diagnostic Criteria for Parkinson Disease

Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822 · see citing works

The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis

Debette, S., & Markus, H. S. (2010) · BMJ · doi:10.1136/bmj.c3666 · Cited by 2,328 · see citing works

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works

Cerebral microbleeds: a guide to detection and interpretation

Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798 · see citing works

A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT

Wahlund, L., Barkhof, F., Fazekas, F., Bronge, L. H., Augustin, M., Sjögren, M. J. C., Wallin, A., Adèr, H. J., Leys, D., Pantoni, L., et al. (2001) · Stroke · doi:10.1161/01.str.32.6.1318 · Cited by 1,797 · see citing works

Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · see citing works

An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp ₇₁₇ ) Mutants

Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471 · see citing works

Clinical Correlates of White Matter Findings on Cranial Magnetic Resonance Imaging of 3301 Elderly People: The Cardiovascular Health Study

Longstreth, W. T., Manolio, T. A., Arnold, A., Burke, G. L., Bryan, N., Jungreis, C. A., Enright, P. L., O'Leary, D., & Fried, L. (1996) · Stroke · doi:10.1161/01.str.27.8.1274 · Cited by 1,464 · see citing works

An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis

Schmidt, P. J., Christian Gaser, B., Arsić, M., Buck, D., Förschler, A., Berthele, A., Hoshi, M., Ilg, R., Schmid, V. J., Zimmer, C., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.032 · Cited by 1,219 · see citing works

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study

Breteler, M. M. B., Swieten, J. C. V., Bots, M. L., Grobbee, D. E., Claus, J. J., Hout, J. H. W. V. D., van Harskamp, F., Tanghe, H. L. J., de Jong, P. T. V. M., van Gijn, J., et al. (1994) · Neurology · doi:10.1212/wnl.44.7.1246 · Cited by 1,006 · see citing works

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · see citing works

Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre

Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849 · see citing works

Alzheimer Disease as a Vascular Disorder

de la Torre, J. C. (2002) · Stroke · doi:10.1161/01.str.0000014421.15948.67 · Cited by 844 · see citing works

The overlap between vascular disease and Alzheimer’s disease - lessons from pathology

Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739 · see citing works

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins

Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560 · see citing works

The Malmö diet and cancer study: representativity, cancer incidence and mortality in participants and non-participants

Manjer, J., Carlsson, S., Elmståhl, S., Gullberg, B., Janzon, L., Lindström, M., Mattisson, I., & Berglund, G. (2001) · European Journal of Cancer Prevention · doi:10.1097/00008469-200112000-00003 · Cited by 543 · see citing works

White Matter Hyperintensities on MRI in the Neurologically Nondiseased Elderly

Ylikoski, A., Erkinjuntti, T., Raininko, R., Sarna, S. J., Sulkava, R. O., & Tilvis, R. S. (1995) · Stroke · doi:10.1161/01.str.26.7.1171 · Cited by 409 · see citing works

Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study

Schrijvers, E. M. C., Verhaaren, B. F. J., Koudstaal, P. J., Hofman, A., Ikram, M. A., & Breteler, M. M. B. (2012) · Neurology · doi:10.1212/wnl.0b013e3182553be6 · Cited by 408 · see citing works

A major role for cardiovascular burden in age-related cognitive decline

Qiu, C., & Fratiglioni, L. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.223 · Cited by 401 · see citing works

Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein Precursor

Davis, J., Xu, F., Deane, R., Romanov, G., Previti, M. L., Zeigler, K., Zlokovic, B. V., & Van Nostrand, W. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312946200 · Cited by 373 · see citing works

Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease

Prelli, F., Castaño, E. M., Glenner, G. G., & Frangione, B. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01087.x · Cited by 351 · see citing works

Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease

Portelius, E., Bogdanovic, N., Gustavsson, M. K., Volkmann, I., Brinkmalm, G., Zetterberg, H., Winblad, B., & Blennow, K. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0690-1 · Cited by 348 · see citing works

Vascular pathology in the aged human brain

Grinberg, L. T., & Thal, D. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0652-7 · Cited by 345 · see citing works

Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy

Gurol, M. E., Irizarry, M. C., Smith, E. E., Raju, S., Diaz-Arrastia, R., Bottiglieri, T., Rosand, J., Growdon, J. H., & Greenberg, S. M. (2006) · Neurology · doi:10.1212/01.wnl.0000191403.95453.6a · Cited by 339 · see citing works

Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden

Qiu, C., Strauss, E. I. V., Bäckman, L., Winblad, B. G., & Fratiglioni, L. (2013) · Neurology · doi:10.1212/wnl.0b013e318292a2f9 · Cited by 307 · see citing works

PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis

Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302 · see citing works

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly

Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Preboske, G. M., Kantarci, K., Raman, M. R., Machulda, M. M., Mielke, M. M., Lowe, V. J., et al. (2015) · Brain · doi:10.1093/brain/awu393 · Cited by 299 · see citing works

β-Amyloid, Blood Vessels, and Brain Function

Smith, E. E., & Greenberg, S. M. (2009) · Stroke · doi:10.1161/strokeaha.108.536839 · Cited by 293 · see citing works

The Profile of Soluble Amyloid β Protein in Cultured Cell Media

Wang, R., Sweeney, D. A., Gandy, S., & Sisodia, S. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31894 · Cited by 293 · see citing works

Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging

Koole, M. J. B., Lewis, D. M., Buckley, C. J., Nelissen, N., Vandenbulcke, M., Brooks, D. J., Vandenberghe, R. R., & Laere, K. V. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060756 · Cited by 212 · see citing works

Cerebrospinal fluid amyloid β₄₀ is decreased in cerebral amyloid angiopathy

Verbeek, M. M., Kremer, B. P. H., Rikkert, M. O., Van Domburg, P. H. M. F., Skehan, M. E., & Greenberg, S. M. (2009) · Annals of Neurology · doi:10.1002/ana.21694 · Cited by 202 · see citing works

Cerebrovascular lesions induce transient  -amyloid deposition

Garcia-Alloza, M., Gregory, J., Kuchibhotla, K. V., Fine, S., Wei, Y., Ayata, C., Frosch, M. P., Greenberg, S. M., & Bacskai, B. J. (2011) · Brain · doi:10.1093/brain/awr300 · Cited by 187 · see citing works

White Matter Changes in Dementia: Role of Impaired Drainage of Interstitial Fluid

Weller, R. O., Hawkes, C. A., Kalaria, R. N., Werring, D. J., & Carare, R. O. (2014) · Brain Pathology · doi:10.1111/bpa.12218 · Cited by 183 · see citing works

Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults

Hedden, T., Mormino, E. C., Amariglio, R. E., Younger, A. P., Schultz, A. P., Becker, J. A., Buckner, R. L., Johnson, K. A., Sperling, R. A., & Rentz, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2462-12.2012 · Cited by 182 · see citing works

Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes

McGowan, E. M., Sanders, S., Iwatsubo, T., Takeuchi, A., Saido, T. C., Zehr, C., Yu, X., Uljon, S., Wang, R., Mann, D. M. A., et al. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0243 · Cited by 180 · see citing works

Disruption of Arterial Perivascular Drainage of Amyloid-β from the Brains of Mice Expressing the Human APOE ε4 Allele

Hawkes, C. A., Sullivan, P. M., Hands, S. L., Weller, R. O., Nicoll, J. A. R., & Carare, R. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041636 · Cited by 177 · see citing works

Associations Between Cerebral Small-Vessel Disease and Alzheimer Disease Pathology as Measured by Cerebrospinal Fluid Biomarkers

Kester, M. I., Goos, J. D. C., Teunissen, C. E., Benedictus, M. R., Bouwman, F. H., Wattjes, M. P., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.754 · Cited by 161 · see citing works

¹¹ C-PIB binding is increased in patients with cerebral amyloid angiopathy–related hemorrhage

Ly, J. V., Donnan, G. A., Villemagne, V. L., Zavala, J. A., Ma, H., O'Keefe, G., Gong, S. J., Gunawan, R. M., Saunder, T., Ackerman, U., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cef7e3 · Cited by 157 · see citing works

Midlife vascular risk factors and the risk of Alzheimer’s disease: A systematic review and meta-analysis

Meng, X.-F., Yu, J.-T., Wang, H.-F., Tan, M.-S., Wang, C., Tan, C.-C., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140954 · Cited by 150 · see citing works

Contemplating Alzheimer’s Disease and the Contribution of White Matter Hyperintensities

Brickman, A. M. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0415-7 · Cited by 136 · see citing works

Cerebrovascular disease, beta-amyloid, and cognition in aging

Marchant, N. L., Reed, B. R., DeCarli, C. S., Madison, C. M., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.001 · Cited by 127 · see citing works

The Aging Brain and Cognition

Marchant, N. L., Reed, B., Sanossian, N., Madison, C. M., Kriger, S., Dhada, R., Mack, W. J., DeCarli, C. S., Weiner, M. W., Mungas, D., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.405 · Cited by 123 · see citing works

Implementation and Validation of an Adaptive Template Registration Method for 18F-Flutemetamol Imaging Data

Lundqvist, R., Lilja, J., Thomas, B. A., Lötjönen, J. M. P., Villemagne, V. L., Rowe, C. C., & Thurfjell, L. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.115006 · Cited by 110 · see citing works

Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment

Park, J., Seo, S. W., Kim, C., Kim, S. H., Kim, G. H., Kim, S. T., Jeon, S., Lee, J. M., Oh, S. J., Kim, J. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.026 · Cited by 83 · see citing works

Cerebral Small Vessel Disease-Induced Apolipoprotein E Leakage Is Associated With Alzheimer Disease and the Accumulation of Amyloid β-Protein in Perivascular Astrocytes

Utter, S., Tamboli, I. Y., Walter, J., Upadhaya, A. R., Birkenmeier, G., Pietrzik, C. U., Ghebremedhin, E., & Thal, D. R. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181836a71 · Cited by 79 · see citing works

Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease

Kotagal, V., Albin, R. L., Müller, M. L. T. M., Koeppe, R. A., Frey, K. A., & Bohnen, N. I. (2014) · Neurology · doi:10.1212/wnl.0000000000000356 · Cited by 77 · see citing works

White matter lesion load is associated with resting state functional MRI activity and amyloid pet but not FDG in mild cognitive impairment and early alzheimer's disease patients

Zhou, Y., Yu, F. F., Duong, T. Q., & Initiative, A. D. N. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24550 · Cited by 76 · see citing works

Independent Generation of Aβ42 and Aβ38 Peptide Species by γ-Secretase

Czirr, E., Cottrell, B. A., Leuchtenberger, S., Kukar, T. L., Ladd, T. B., Esselmann, H., Paul, S., Schubenel, R., Torpey, J. W., Pietrzik, C. U., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802912200 · Cited by 72 · see citing works

Diagnostic Utility of Amyloid PET in Cerebral Amyloid Angiopathy-Related Symptomatic Intracerebral Hemorrhage

Baron, J., Farid, K., Dolan, E., Turc, G., Marrapu, S. T., O'Brien, E., Aigbirhio, F. I., Fryer, T. D., Menon, D. K., Warburton, E. A., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.43 · Cited by 65 · see citing works

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid

Selnes, P., Blennow, K., Zetterberg, H., Grambaitė, R., Rosengren, L., Johnsen, L., Stenset, V. T. V., & Fladby, T. (2010) · Cerebrospinal Fluid Research · doi:10.1186/1743-8454-7-10 · Cited by 52 · see citing works

Aβ38 in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models

Reinert, J., Martens, H., Hüttenrauch, M., Kolbow, T., Lannfelt, L., Ingelsson, M., Paetau, A. E., Verkkoniemi‐Ahola, A., Bayer, T. A., & Wirths, O. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131373 · Cited by 33 · see citing works

Amyloid and tau in the brain in sporadic Alzheimer’s disease: defining the chicken and the egg

Hawkes, C. A., Carare, R. O., & Weller, R. O. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1243-9 · Cited by 14 · see citing works

Enhanced Aβ40 Deposition Was Associated with Increased Aβ42/43 in Cerebral Vasculature with Dutch‐Type Hereditary Cerebral Hemorrhage with Amyloidosis (HCHWA‐D)

Ozawa, K., Tomiyama, T., Maat–Schieman, M. L. C., Roos, R. A. C., & Mori, H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04810.x · Cited by 11 · see citing works

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

Palmqvist, S., Schöll, M., Strandberg, O., Mattsson, N., Stomrud, E., Zetterberg, H., Blennow, K., Landau, S., Jagust, W., & Hansson, O. (2017) · Nature Communications · doi:10.1038/s41467-017-01150-x · Cited by 911 · see citing works

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

Hansson, O., Lehmann, S., Otto, M., Zetterberg, H., & Lewczuk, P. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0485-0 · Cited by 585 · see citing works

White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies

Hu, H., Ou, Y., Shen, X., Qu, Y., Ma, Y., Wang, Z.-T., Dong, Q., Tan, L., & Yu, J. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.11.007 · Cited by 290 · see citing works

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

Cullen, N. C., Leuzy, A., Janelidze, S., Palmqvist, S., Svenningsson, A. L., Stomrud, E., Dage, J. L., Mattsson, N., & Hansson, O. (2021) · Nature Communications · doi:10.1038/s41467-021-23746-0 · Cited by 270 · see citing works

Biomarker-based staging of Alzheimer disease: rationale and clinical applications

Therriault, J., Schindler, S. E., Salvadó, G., Pascoal, T. A., Benedet, A. L., Ashton, N. J., Karikari, T. K., Apostolova, L. G., Murray, M. E., Verberk, I. M. W., et al. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00942-2 · Cited by 206 · see citing works

Determining clinically meaningful decline in preclinical Alzheimer disease

Insel, P. S., Weiner, M., Mackin, R. S., Mormino, E., Lim, Y. Y., Stomrud, E., Palmqvist, S., Masters, C. L., Maruff, P. T., Hansson, O., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007831 · Cited by 128 · see citing works

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

Leuzy, A., Chiotis, K., Hasselbalch, S. G., Rinne, J. O., de Mendonça, A., Otto, M., Lleó, A., Castelo-Branco, M. S., Santana, I. J., Johansson, J. J., et al. (2016) · Brain · doi:10.1093/brain/aww160 · Cited by 132 · see citing works

Cerebral Small Vessel Disease and Alzheimer's Disease: A Review

Kim, H. W., Hong, J., & Jeon, J. C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00927 · Cited by 108 · see citing works

The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer's disease: A positron emission tomography study in rats

Park, J., Hong, J., Lee, S., Ji, H. D., Jung, J.-A., Yoon, K.-W., Lee, J.-I., Won, K. S., Song, B., & Kim, H. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-50681-4 · Cited by 96 · see citing works

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease

Leuzy, A., Bollack, A., Pellegrino, D., Teunissen, C. E., Joie, R. L., Rabinovici, G. D., Franzmeier, N., Johnson, K. A., Barkhof, F., Shaw, L. M. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14528 · Cited by 97 · see citing works

Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease

Levit, A., Hachinski, V., & Whitehead, S. N. (2020) · GeroScience · doi:10.1007/s11357-020-00164-6 · Cited by 89 · see citing works

Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross‐validation study against amyloid PET

Pannee, J., Portelius, E., Minthon, L., Gobom, J., Andréasson, U., Zetterberg, H., Hansson, O., & Blennow, K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13838 · Cited by 84 · see citing works

Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer’s Coordinating Center Uniform Data Set

Puzo, C. J., Labriola, C., Sugarman, M. A., Tripodis, Y., Martin, B. M., Palmisano, J. N., Steinberg, E. G., Stein, T. D., Kowall, N. W., McKee, A. C., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0521-0 · Cited by 84 · see citing works

White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease

Soldan, A., Pettigrew, C. A., Zhu, Y., Wang, M., Moghekar, A., Gottesman, R. F., Singh, B., Martinez, O., Fletcher, E. M., DeCarli, C. S., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008864 · Cited by 82 · see citing works

Amyloid‐beta 1‐40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro

Schultz, N., Brännström, K., Byman, E., Moussaud, S., Nielsen, H. M., Bank, T. N. B., Olofsson, A., & Wennström, M. (2018) · Aging Cell · doi:10.1111/acel.12728 · Cited by 73 · see citing works

Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions

Weaver, N. A., Doeven, T., Barkhof, F., Biesbroek, J. M., Groeneveld, O. N., Kuijf, H. J., Prins, N. D., Scheltens, P., Teunissen, C. E., van der Flier, W. M., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.001 · Cited by 71 · see citing works

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Mattsson, N., Palmqvist, S., Blennow, K., & Hansson, O. (2020) · Nature Communications · doi:10.1038/s41467-020-19957-6 · Cited by 69 · see citing works

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

Leuzy, A., Ashton, N. J., Mattsson, N., Dodich, A., Boccardi, M., Corre, J., Drzezga, A. E., Nordberg, A. K., Ossenkoppele, R., Zetterberg, H., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05258-7 · Cited by 69 · see citing works

Association of small vessel disease with tau pathology

Kapasi, A., Yu, L., Petyuk, V., Arfanakis, K., Bennett, D. A., & Schneider, J. A. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02397-x · Cited by 55 · see citing works

Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes

Cicognola, C., Mattsson, N., van Westen, D., Zetterberg, H., Blennow, K., Palmqvist, S., Ahmadi, K., Strandberg, O. T., Stomrud, E., Janelidze, S., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207358 · Cited by 52 · see citing works

Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities

Osborn, K. E., Liu, D., Samuels, L. R., Moore, E. E., Cambronero, F. E., Acosta, L. M. Y., Bell, S. P., Babicz, M. A., Gordon, E. A., Pechman, K. R., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.028 · Cited by 51 · see citing works

Invited Review: The spectrum of age‐related small vessel diseases: potential overlap and interactions of amyloid and nonamyloid vasculopathies

Schreiber, S., Wilisch-Neumann, A., Schreiber, F., Assmann, A., Scheumann, V., Perosa, V., Jandke, S., Mawrin, C., Carare, R. O., & Werring, D. J. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12576 · Cited by 49 · see citing works

Are the brain's vascular and Alzheimer pathologies additive or interactive?

Koncz, R., & Sachdev, P. S. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000395 · Cited by 46 · see citing works

Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET

Ottoy, J., Ozzoude, M., Zukotynski, K., Adamo, S. M., Scott, C. J. M., Gaudet, V., Ramirez, J., Swardfager, W., Cogo‐Moreira, H., Lam, B., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12750 · Cited by 46 · see citing works

Portable, low-field magnetic resonance imaging for evaluation of Alzheimer’s disease

Sorby‐Adams, A., Guo, J. D., Laso, P., KIRSCH, J. E., Zabinska, J., Guarniz, A. G., Schaefer, P. W., Payabvash, S., de Havenon, A., Rosen, M. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54972-x · Cited by 45 · see citing works

Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions

Lv, X., Zhang, M., Cheng, Z., Wang, Q., Wang, P., Xie, Q., Ni, M., Shen, Y., Tang, Q., & Gao, F. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01199-5 · Cited by 44 · see citing works

Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer’s Disease

Santangelo, R., Cecchetti, G., Bernasconi, M. P., Cardamone, R., Barbieri, A., Pinto, P., Passerini, G., Scomazzoni, F., Comı, G., & Magnani, G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170186 · Cited by 40 · see citing works

Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort

Jang, H., Kim, J. S., Lee, H. J., Kim, C., Na, D. L., Kim, H. J., Allué, J. A., Sarasa, L., Castillo, S., Pesini, P., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00911-7 · Cited by 36 · see citing works

Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease

Wang, T., Jin, A., Fu, Y., Zhang, Z., Li, S., Wang, D., & Wang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803504 · Cited by 36 · see citing works

Visual interpretation of [18F]Florbetaben PET supported by deep learning–based estimation of amyloid burden

Kim, J.-Y., Oh, D., Sung, K., Choi, H., Paeng, J. C., Cheon, G. J., Kang, K. W., Lee, D. Y., & Lee, D. S. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05044-x · Cited by 33 · see citing works

Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer's disease

Zhang, J., Wu, N., Wang, S., Yao, Z., Xiao, F., Lu, J., & Chen, B. (2021) · Aging Cell · doi:10.1111/acel.13380 · Cited by 33 · see citing works

Association of white matter hyperintensities with cognitive decline and neurodegeneration

Li, T., Li, B.-L., Xu, X., Zhong, J., Wang, T.-S., Liu, F., & Initiative, T. A. D. N. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1412735 · Cited by 30 · see citing works

Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice

Finch, C. E., & Shams, S. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.07.002 · Cited by 29 · see citing works

Regional White Matter Hyperintensities and Alzheimer’s Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment

Newton, P., the BIOCARD Research Team, Tchounguen, J., Pettigrew, C., Lim, C., Lin, Z., Lu, H., Moghekar, A., Albert, M., & Soldan, A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220846 · Cited by 23 · see citing works

A Review of the Pathogenesis and Chinese Medicine Intervention of Alzheimer's Disease

Zhao, J., Yang, J., Li, D., Wang, F., & Li, L. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2201002 · Cited by 21 · see citing works

Association between white matter lesions and cerebral Aβ burden

Yi, H., Won, K. S., Chang, H. W., & Kim, H. W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204313 · Cited by 21 · see citing works

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

Mattsson, N., Eriksson, O., Lindberg, O. E., Schöll, M., Lampinen, B., Nilsson, M., Insel, P. S., Lautner, R., Strandberg, O. T., van Westen, D., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.003 · Cited by 20 · see citing works

Low Cerebrospinal Fluid Aβ 42 and Aβ 40 are Related to White Matter Lesions in Cognitively Normal Elderly

Skoog, I. G., Kern, S., Zetterberg, H., Östling, S., Börjesson‐Hanson, A., Guo, X., & Blennow, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170950 · Cited by 17 · see citing works

The cross-sectional association between amyloid burden and white matter hyperintensities in older adults without cognitive impairment: A systematic review and meta-analysis

Twait, E. L., Min, B., Beran, M., Vonk, J. M. J., & Geerlings, M. I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101952 · Cited by 14 · see citing works

Influence of Alzheimer's Disease Related Neuropathology on Local Microenvironment Gene Expression in the Human Inferior Temporal Cortex

Kwon, S. H., Parthiban, S., Tippani, M., Divecha, H. R., Eagles, N. J., Lobana, J. S., Williams, S. R., Mak, M., Bharadwaj, R. A., Kleinman, J. E., et al. (2023) · GEN Biotechnology · doi:10.1089/genbio.2023.0019 · Cited by 14 · see citing works

Connexin43 Contributes to Alzheimer’s Disease by Promoting the Mitochondria-Associated Membrane-Related Autophagy Inhibition

Yu, W., Li, Y., Li, Y., Hu, J., Wu, J., Chen, X., Huang, Y., & Shi, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04536-3 · Cited by 15 · see citing works

Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy

Svenningsson, A. L., Stomrud, E., Palmqvist, S., Hansson, O., & Ossenkoppele, R. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01081-w · Cited by 14 · see citing works

Comorbidity of Cerebrovascular and Alzheimer’s Disease in Aging

Xia, Y., Yassi, N., Raniga, P., Bourgeat, P., Desmond, P. M., Doecke, J. D., Ames, D. J., Laws, S. M., Fowler, C. J., Rainey‐Smith, S. R., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200419 · Cited by 12 · see citing works

Cerebral white matter burden is linked to cognitive function in patients undergoing hemodialysis

Wu, T.-S., Wu, P., Lin, H., Chen, W., Huang, T.-H., Lin, M., Chuang, Y., Yang, F., Chiu, Y., Chang, J., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2310142 · Cited by 11 · see citing works

Association between white matter lesions and cerebral glucose metabolism in patients with cognitive impairment

No, H.-J., Yi, H., Won, K. S., Chang, H. W., & Kim, H. W. (2019) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2019.01.005 · Cited by 11 · see citing works

Effects of amyloid pathology and the APOE ε4 allele on the association between cerebrospinal fluid Aβ38 and Aβ40 and brain morphology in cognitively normal 70-years-olds

Lindberg, O. E., Kern, S., Skoog, J., Machado, A., Pereira, J. B., Sacuiu, S. F., Wahlund, L., Blennow, K., Zetterberg, H., Zettergren, A., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.10.033 · Cited by 10 · see citing works

Alzheimer’s disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults

Soldan, A., Wang, J., Pettigrew, C. A., Davatzikos, C. A., Erus, G., Hohman, T. J., Dumitrescu, L. C., Bilgel, M., Resnick, S. M., Rivera‐Rivera, L. A., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae276 · Cited by 10 · see citing works

White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease

Kuroda, T., Honma, M., Mori, Y., Futamura, A., Sugimoto, A., Kasai, H., Yano, S., Hieda, S., Kasuga, K., Ikeuchi, T., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215187 · Cited by 10 · see citing works

Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia

Eckerström, C., Eckerström, M., Göthlin, M., Molinder, A., Jonsson, M. A. G., Kettunen, P., Svensson, J., Rolstad, S., & Wallin, A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190651 · Cited by 10 · see citing works

Regional white matter hyperintensity volume predicts persistent cognitive impairment in acute lacunar infarct patients

Li, T., Ye, M.-F., Yang, G., Diao, S., Zhou, Y., Qin, Y., Ding, D., Zhu, M., & Fang, Q. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1265743 · Cited by 9 · see citing works

Blood-brain barrier-associated biomarker correlated with cerebral small vessel disease and shunt outcome in normal pressure hydrocephalus: a prospective cohort study

Tseng, P.-H., Huang, L.-C., Huang, X.-L., Huang, B., Lin, S., Tsai, S., & Huang, H.-Y. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002038 · Cited by 6 · see citing works

Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer’s Disease

Golas, A., on behalf of the PACt-MD Study Group, Salwierz, P., Rajji, T. K., Bowie, C. R., Butters, M. A., Fischer, C. E., Flint, A. J., Herrmann, N., Mah, L., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221097 · Cited by 5 · see citing works

Challenges in Alzheimer’s Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences

Lombardi, G., Pupi, A., Bessi, V., Polito, C., Padiglioni, S., Ferrari, C., Lucidi, G., Berti, V., Cristofaro, M. T. D., Piaceri, I., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200119 · Cited by 5 · see citing works

Asociación entre daños en la sustancia blanca y metabolismo de la glucosa cerebral en pacientes con disfunción cognitiva

No, H.-J., Yi, H.-A., Won, K. S., Chang, H. W., & Kim, H. W. (2019) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2018.12.001 · Cited by 4 · see citing works

Association between ABO genotypes and risk of dementia and neuroimaging markers: roles of sex and APOE status

Li, M., Yu, R., Wang, X., Zhao, Y., Song, Q., Wang, Q., Fu, C., Mishra, S. R., Shrestha, N., Virani, S. S., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1391010 · Cited by 2 · see citing works

Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia

Mattsson, N., Grigoriou, S., & Zetterberg, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_11 · Cited by 2 · see citing works

Decreased Cerebrospinal Fluid Aβ42 in Patients with Idiopathic Parkinson’s Disease and White Matter Lesions

Markaki, I., Klironomos, S., & Svenningsson, P. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-181486 · Cited by 2 · see citing works

Clinical utility of CSF Aβ38 in Japanese research and clinical cohorts

Tsukie, T., Kasuga, K., Kikuchi, M., Ishiguro, T., Miyashita, A., Onodera, O., Iwatsubo, T., Initiative, J. A. D. N., & Ikeuchi, T. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70125 · Cited by 1 · see citing works

CEST MRI Processing Pipeline in Pilot Study of Alzheimer's Disease Patients

Asturias, A., Yu, F. F., Davenport, E. M., Kelley, B. J., Dimitrov, I. E., Keupp, J., & Vinogradov, E. (2026) · Magnetic Resonance in Medicine · doi:10.1002/mrm.70240 · Cited by 1 · see citing works

Association between Cerebral Small Vessel and Alzheimer’s Disease

Lee, K. H., & Kang, K. M. (2022) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2022.0041 · Cited by 1 · see citing works

White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease

Kasahara, H., Ikeda, M., Makioka, K., Nakamura, T., Takahashi, R., Kawarabayashi, T., Sanada, E., Suto, T., Higuchi, T., Tsushima, Y., et al. (2025) · Journal of Alzheimer’s Disease · doi:10.1177/13872877251316516

Voxel-Wise Image Analysis for White Matter Hyperintensity SegmentationPreprint

Knight, J. (2018) · doi:10.31237/osf.io/8y6s7

Комплексный метод анализа геометрической точности цилиндров в процессе сборки судовых малоразмерных дизелей

Яхьяевич, Я. Н., & Vagabov, N. M. (2009) · VESTNIK OF ASTRAKHAN STATE TECHNICAL UNIVERSITY SERIES MARINE ENGINEERING AND TECHNOLOGIES

Additional file 1 of Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions

Lv, X., Zhang, M., Cheng, Z., Wang, Q., Wang, P., Xie, Q., Ni, M., Shen, Y., Tang, Q., & Gao, F. (2023) · Figshare · doi:10.6084/m9.figshare.22620493

Additional file 1 of Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy

Svenningsson, A. L., Stomrud, E., Palmqvist, S., Hansson, O., & Ossenkoppele, R. (2022) · Figshare · doi:10.6084/m9.figshare.21269527

Traditional Chinese Medicine for Alzheimer’s Disease: Current Evidence and Chemometric Approaches for Multi-Target Evaluation

Sun, X., Yang, L., & 王香明 (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s590661

P1‐099: White matter lesions but not lacunes are associated with the CSF levels of Aβ38 and Aβ40, and to a lesser degree with CSF Aβ42

van Westen, D., Lindqvist, D., Palmqvist, S., Stomrud, E., Minthon, L., Nägga, K., Blennow, K., Zetterberg, H., & Hansson, O. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.296

Cerebral white matter lesions - associations with A beta isoforms and amyloid PET

van Westen, D., Lindqvist, D., Blennow, K., Minthon, L., Nagga, K., Stomrud, E., Zetterberg, H., & Hansson, O. (2016) · UCL Discovery (University College London)

Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology

McAleese, K. E., Miah, M., Graham, S., Hadfield, G. M., Walker, L., Johnson, M. A., Colloby, S. J., Thomas, A. J., DeCarli, C. S., Koss, D. J., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02376-2 · Cited by 95 · see citing works

P1‐373: βETA‐AMYLOID AND WHITE MATTER LESIONS ARE INDEPENDENTLY ASSOCIATED WITH HIPPOCAMPAL ATROPHY AND REDUCED CORTICAL TEMPORAL THICKNESS

Svenningsson, A. L., Stomrud, E., Palmqvist, S., & Hansson, O. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.381

Cerebrospinal fluid biomarkers of white matter lesions – cross‐sectional results from the LADIS study

Jonsson, M. A. G., Zetterberg, H., van Straaten, E. C. W., LIND, K., Syversen, S., Edman, Å., Blennow, K., Rosengren, L., Pantoni, L., Inzitari, D., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02808.x · Cited by 111 · see citing works